Mereo BioPharma, Cyclo Therapeutics lidera los ganadores de la atención médica; Mesoblast, Virios Therapeutics entre los principales perdedores
Ganadores : Mereo BioPharma (NASDAQ: MREO ) + 91%, Cyclo Therapeutics (CYTH) + 44%, Petros Pharmaceuticals (PTPI) + 29%, CNS Pharmaceuticals (NASDAQ: CNSP ) + 17%, Humanigen (NASDAQ: HGEN ) +17 % .
Perdedores: Mesoblast (NASDAQ: MESO ) -34%, Virios Therapeutics (NASDAQ: VIRI ) -30%, BioCardia (NASDAQ: BCDA ) -14%, Greenwich LifeSciences (NASDAQ: GLSI ) -12%, Zhongchao (NASDAQ: ZCMD ) -10%.
